ResMed Inc. Revenues
ResMed Inc. (RMD) reported Revenues of $2.96 billion for the 12-month period ending 2020-06-30, per its 10-K filed 2020-08-13.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2020-08-13
- ResMed Inc. revenues for the quarter ending 2020-06-30 was $770.34M, a 9.27% increase year-over-year.
- ResMed Inc. revenues for the quarter ending 2020-03-31 was $769.46M, a 16.19% increase year-over-year.
- ResMed Inc. revenues for the quarter ending 2019-12-31 was $736.16M, a 13.06% increase year-over-year.
- ResMed Inc. revenues for the quarter ending 2019-09-30 was $681.06M, a 15.77% increase year-over-year.
- ResMed Inc. revenues for fiscal 2020 was $2.96B, a 13.44% increase from fiscal 2019.
- ResMed Inc. revenues for fiscal 2019 was $2.61B, a 11.38% increase from fiscal 2018.
- ResMed Inc. revenues for fiscal 2018 was $2.34B, a 13.23% increase from fiscal 2017.
- ResMed Inc. revenues for fiscal 2017 was $2.07B, a 12.40% increase from fiscal 2016.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2020-06-30 | $770.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $1.54B derived: sum of 2 quarters · filed 2020-08-13 | $2.28B derived: sum of 3 quarters · filed 2020-08-13 | $2.96B 10-K · filed 2020-08-13 |
| 2020-03-31 | $769.46M 10-Q · filed 2020-05-01 | $1.51B derived: sum of 2 quarters · filed 2020-05-01 | $2.19B 10-Q · filed 2020-05-01 | $2.89B derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-12-31 | $736.16M 10-Q · filed 2020-01-31 | $1.42B 10-Q · filed 2020-01-31 | $2.12B derived: sum of 3 quarters · filed 2020-08-13 | $2.78B derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-09-30 | $681.06M 10-Q · filed 2019-10-25 | $1.39B derived: sum of 2 quarters · filed 2020-08-13 | $2.05B derived: sum of 3 quarters · filed 2020-08-13 | $2.70B derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-06-30 | $704.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $1.37B derived: sum of 2 quarters · filed 2020-08-13 | $2.02B derived: sum of 3 quarters · filed 2020-08-13 | $2.61B 10-K · filed 2020-08-13 |
| 2019-03-31 | $662.23M 10-Q · filed 2020-05-01 | $1.31B derived: sum of 2 quarters · filed 2020-05-01 | $1.90B 10-Q · filed 2020-05-01 | $2.53B derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-12-31 | $651.10M 10-Q · filed 2020-01-31 | $1.24B 10-Q · filed 2020-01-31 | $1.86B derived: sum of 3 quarters · filed 2020-08-13 | $2.45B derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-09-30 | $588.28M 10-Q · filed 2019-10-25 | $1.21B derived: sum of 2 quarters · filed 2020-08-13 | $1.80B derived: sum of 3 quarters · filed 2020-08-13 | $2.40B derived: sum of 4 quarters · filed 2020-08-13 |
| 2018-06-30 | $623.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $1.22B derived: sum of 2 quarters · filed 2020-08-13 | $1.82B derived: sum of 3 quarters · filed 2020-08-13 | $2.34B 10-K · filed 2020-08-13 |
| 2018-03-31 | $591.63M 10-Q · filed 2019-05-03 | $1.19B derived: sum of 2 quarters · filed 2019-05-03 | $1.72B 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $601.27M 10-Q · filed 2019-02-01 | $1.12B 10-Q · filed 2019-02-01 | ||
| 2017-09-30 | $523.66M 10-Q · filed 2018-10-26 | |||
| 2017-06-30 | $2.07B 10-K · filed 2019-08-08 | |||
| 2016-06-30 | $1.84B 10-K · filed 2018-08-17 | |||
| 2015-06-30 | $1.68B 10-K · filed 2017-08-04 | |||
| 2014-06-30 | $1.55B 10-K · filed 2016-08-05 | |||
| 2013-06-30 | $1.51B 10-K · filed 2015-08-07 | |||
| 2012-06-30 | $1.37B 10-K · filed 2014-08-08 |